AGIX

(redirected from AtheroGenics, Inc)
AcronymDefinition
AGIXAtheroGenics, Inc (stock symbol)
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
(Toronto, Canada) congratulated AtheroGenics, Inc. on the signing of a significant commercialization agreement for AGI-1067, its novel oral therapy for the treatment of atherosclerosis.
AtheroGenics, Inc., Atlanta, GA announced it has begun a Phase I clinical trial of AGI-1096 as an oral treatment for the prevention of organ transplant rejection.
AtheroGenics, Inc., Atlanta, GA announced it has filed a Investigational New Drug (IND) application with the US Food and Drug Administration (FDA) for AGI-1096, a novel, oral drug for the prevention of organ transplant rejection.